RecruitingPhase 3NCT06205095

A Pilot Crossover Trial of Prophylactic Wilate Compared to Placebo for Heavy Menstrual Bleeding in Patients with VWD

Studying Von Willebrand disease

Last synced from ClinicalTrials.gov

ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data

Key facts

Sponsor
Unity Health Toronto
Intervention
Lyophilized concentrate of human coagulation von Willebrand Factor and factor VIII(drug)
Enrollment
20 target
Eligibility
18 years · FEMALE
Timeline
2024 – 2026

Study locations (1)

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT06205095 on ClinicalTrials.gov

Other trials for Von Willebrand disease

Additional recruiting or active studies for the same condition.

See all trials for Von Willebrand disease →

← Back to all trials